Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High Dose Testosterone + Carboplatin in Advanced Prostate Cancer
NCT03522064Phase 2Recruiting
- Sponsor
- St Vincent's Hospital
- Start
- Jul 2018
- Primary completion
- Sep 2026
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of testosterone enanthate, carboplatin in castration-resistant prostate cancer (CRPC), sponsored by St Vincent's Hospital. Started Jul 2018; status: recruiting.
02
Drugs
testosterone enanthatecarboplatin
03
Conditions
castration-resistant prostate cancer (CRPC)
Beyond the preview
Go deeper on NCT03522064.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03522064.